Clinical Trial Update: Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating heart function in patients with rheumatoid arthritis and ankylosing spondylitis before and after TNF blocker therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Rheumatoid Arthritis

Drugs mentioned

• TNF inhibitor (tumor necrosis factor blocker) (tumor necrosis factor inhibitor)

Snippet

Sponsor: University of Sao Paulo | Conditions: Arthritis, Rheumatoid, Spondylitis, Ankylosing | Phase 4 | Status: UNKNOWN